MUHAMMAD ABDULLAH: Open Payments
NPI 1265446405 · NEWARK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 95 payments from 23 companies in 2025. Trend: 2023 $2,099 · 2024 $1,907 · 2025 $1,667
Food & beverage: $1,667
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $266 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $160 |
| Novo Nordisk Inc | 9 | $160 |
| Ardelyx, Inc. | 7 | $158 |
| ABBVIE INC. | 12 | $144 |
| Merck Sharp & Dohme LLC | 7 | $126 |
| Kowa Pharmaceuticals America, Inc. | 6 | $85 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| PFIZER INC. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $55 |
Products named: JARDIANCE, IBSRELA, BREZTRI, Ozempic, FARXIGA, VERQUVO, ZORYVE, VRAYLAR.
Industry payments across NJ — which companies pay providers there.
